ATE292674T1 - Neue antigenklasse von geflügelreoviren - Google Patents

Neue antigenklasse von geflügelreoviren

Info

Publication number
ATE292674T1
ATE292674T1 AT00200256T AT00200256T ATE292674T1 AT E292674 T1 ATE292674 T1 AT E292674T1 AT 00200256 T AT00200256 T AT 00200256T AT 00200256 T AT00200256 T AT 00200256T AT E292674 T1 ATE292674 T1 AT E292674T1
Authority
AT
Austria
Prior art keywords
poultry
reoviruses
new antigen
antigen class
provides
Prior art date
Application number
AT00200256T
Other languages
German (de)
English (en)
Inventor
Loon Adriaan Anthonius Wil Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE292674T1 publication Critical patent/ATE292674T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT00200256T 1999-01-29 2000-01-25 Neue antigenklasse von geflügelreoviren ATE292674T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200259 1999-01-29

Publications (1)

Publication Number Publication Date
ATE292674T1 true ATE292674T1 (de) 2005-04-15

Family

ID=8239847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00200256T ATE292674T1 (de) 1999-01-29 2000-01-25 Neue antigenklasse von geflügelreoviren

Country Status (16)

Country Link
US (1) US6951650B1 (enExample)
EP (1) EP1024189B1 (enExample)
JP (2) JP4659942B2 (enExample)
KR (1) KR100583259B1 (enExample)
AT (1) ATE292674T1 (enExample)
AU (1) AU759179B2 (enExample)
BR (1) BR0000190A (enExample)
CA (1) CA2297345C (enExample)
DE (1) DE60019178T2 (enExample)
ES (1) ES2240005T3 (enExample)
HU (1) HU225434B1 (enExample)
MX (1) MXPA00001001A (enExample)
PL (1) PL192277B1 (enExample)
PT (1) PT1024189E (enExample)
RU (1) RU2265659C2 (enExample)
ZA (1) ZA200000370B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006503863A (ja) * 2002-09-16 2006-02-02 ワイス トリ吸収不良症候群に関与するウイルスを含有するワクチンおよびその投与法
JP2006516146A (ja) * 2002-10-09 2006-06-22 アクゾ・ノベル・エヌ・ベー トリレオウイルスにより引き起こされる神経学的症状の治療および予防方法ならびに新規付随的特徴
WO2008076518A2 (en) * 2006-10-25 2008-06-26 University Of Georgia Research Foundation, Inc. Reovirus compositions and methods of use
BRPI0910185A2 (pt) * 2008-06-26 2015-12-01 Ceva Sante Animale S A sorotipo de reovírus aviário isolado, reovírus aviário isolado, peptídeos, vacina, antisoro isolado, anticorpo isolado, método para proteção de aves, método para detecção ou quantificação de reovírus em aves, recipiente para vacinação de aves, kit para vacinação de aves, kit de diagnóstico, linhagem celular derivada da lmh
WO2010059899A2 (en) * 2008-11-20 2010-05-27 University Of Georgia Research Foundation, Inc. Vaccine for runting-stunting syndrome
CA2725435C (en) 2009-12-15 2023-01-03 University Of Saskatchewan Vaccines for inclusion body hepatitis
KR101600959B1 (ko) 2013-06-18 2016-03-08 단국대학교 산학협력단 가금 레오바이러스 시그마 c 단백질의 항원 결정기를 포함하는 재조합 단백질 및 이에 대한 항체
KR102340265B1 (ko) * 2014-01-29 2021-12-15 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 조류 레오바이러스 백신
HUE063529T2 (hu) * 2014-10-03 2024-01-28 Intervet Int Bv Szélesspektrumú vakcina madár reovírus ellen
CN104711240B (zh) * 2015-03-18 2017-10-10 广西壮族自治区兽医研究所 禽呼肠孤病毒σA蛋白及其相关生物材料的应用
AU2017204942B2 (en) * 2016-01-07 2020-11-26 Gavish-Galilee Bio Applications, Ltd Optimized polypeptide for a subunit vaccine against avian reovirus
CN108794627A (zh) * 2018-07-03 2018-11-13 重庆永健生物技术有限责任公司 一种鸭呼肠孤病毒精制卵黄抗体的制备方法
CN111000992A (zh) * 2019-12-19 2020-04-14 广州渔跃生物技术有限公司 一种鸭呼肠孤病毒、鸭坦布苏病毒和鸭腺病毒三联灭活疫苗及其制备方法
CN116478937B (zh) * 2023-06-12 2023-08-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 基因iii型禽呼肠孤病毒变异株及其在制备疫苗中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559229A (en) * 1982-07-20 1985-12-17 Research Foundation Avian proventriculitis vaccine
US5525342A (en) * 1994-05-20 1996-06-11 Akzo Nobel, N.V. Reovirus strain 2177 and vaccine containing same

Also Published As

Publication number Publication date
AU1362900A (en) 2000-08-03
US6951650B1 (en) 2005-10-04
EP1024189A1 (en) 2000-08-02
CA2297345C (en) 2010-07-13
PL192277B1 (pl) 2006-09-29
MXPA00001001A (es) 2002-03-08
PT1024189E (pt) 2005-08-31
HU225434B1 (en) 2006-11-28
AU759179B2 (en) 2003-04-10
EP1024189B1 (en) 2005-04-06
HUP0000362A3 (en) 2005-04-28
KR20010069166A (ko) 2001-07-23
RU2265659C2 (ru) 2005-12-10
BR0000190A (pt) 2001-08-21
JP4659942B2 (ja) 2011-03-30
HU0000362D0 (en) 2000-04-28
DE60019178T2 (de) 2005-09-08
CA2297345A1 (en) 2000-07-29
ZA200000370B (en) 2000-08-07
JP2011092190A (ja) 2011-05-12
JP2000295986A (ja) 2000-10-24
KR100583259B1 (ko) 2006-05-25
ES2240005T3 (es) 2005-10-16
PL338118A1 (en) 2000-07-31
HUP0000362A2 (hu) 2000-11-28
DE60019178D1 (de) 2005-05-12

Similar Documents

Publication Publication Date Title
DE60019178D1 (de) Neue Antigenklasse von Geflügelreoviren
DZ2462A1 (fr) Vaccin antigrippal.
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
FR2763244B1 (fr) Composition vaccinale multivalente a porteur mixte
EP1731605A4 (en) CANCERANT PEPTIDES FROM WT1
DK1382348T3 (da) Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom
DK1282702T3 (da) Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf
FR2728795B1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
NO20041917D0 (no) Spesifikke midler som binder humant angiopoietin-2
CY1107841T1 (el) Φαρμακευτικα σκευασματα τα οποια περιλαμβανουν μυκοφαινολικο οξυ ή μυκοφαινολικο αλας
ATE542829T1 (de) Impfstoff
DE50212615D1 (de) Lyophilisierte zubereitung enthaltend antikörper gegen den egf-rezeptor
ATE255419T1 (de) Für den vogelembryo geeignete multivalente impfstoffe
BRPI0418317A (pt) vacina de aumento de crescimento à base de epitopo de neutralização
UA84284C2 (ru) Способы лечения, профилактики и диагностики инфекции helicobacter cerdo
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
DE60042816D1 (de) T-helferzellen-epitope
DK0838222T3 (da) Vaccinesammensætninger, der omfatter inaktiverede immunogener og levende kyllingeanæmi-virus (CAV)
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
ATE334697T1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
CL2010001175A1 (es) Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv).
ES2502366T3 (es) Inducción de inmunidad tumoral por variantes de proteína de unión a folato
DE60042489D1 (de) Impfstoff gegen neisseria infektion
ATE206310T1 (de) Aviären infektiösen anämie mastgeflügel impfstoff
EP1210364A4 (en) VACCINE ANTIGENS FROM MORAXELLA

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties